Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674196 | SCV000799492 | pathogenic | Sandhoff disease | 2018-04-25 | criteria provided, single submitter | clinical testing | |
Foundation for Research in Genetics and Endocrinology, |
RCV000674196 | SCV002817381 | pathogenic | Sandhoff disease | 2022-12-26 | criteria provided, single submitter | clinical testing | A compound heterozygous status for the variant c.333G>A in Exon 2 of the HEXB gene was detected. The variants have not been reported in the 1000 genomes database and has a MAF of 0.0008% in the gnomAD database. The in-silico prediction is disease causing by Mutation Taster and DANN. In summary, the variant meets our criteria to be classified as pathogenic. |
Labcorp Genetics |
RCV000674196 | SCV003294567 | pathogenic | Sandhoff disease | 2024-08-23 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp111*) in the HEXB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HEXB are known to be pathogenic (PMID: 7550345, 18758829). This variant is present in population databases (rs761117459, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with Sandhoff disease (PMID: 26582265). ClinVar contains an entry for this variant (Variation ID: 557986). For these reasons, this variant has been classified as Pathogenic. |